Skip to main content
. 2020 Apr 27;12(5):281. doi: 10.3390/toxins12050281

Table 4.

Variabilities of EC80 and EC50 for two VGSC activators (P-CTX3C and PbTx3) using the revisited CBA-N2a as assessed under non-destructive O/V treatment conditions.

Variability O/V Treatment P-CTX3C PbTx3
EC80 (fg/µL) EC50 (fg/µL) EC80 (fg/µL) EC50 (fg/µL)
Inter-assay * 100/10 µM 0.787 ± 0.155 1.700 ± 0.354 2950 ± 538 5800 ± 929
Intra-assay ** 85.7/8.57 µM 0.964 ± 0.055 2.004 ± 0.190 3230 ± 270 6241 ± 388
Inter-assay *** 85.7/8.57 µM 0.825 ± 0.236 1.730 ± 0.414 3015 ± 347 5946 ± 788

* Data represent the mean ± SD of one microplate in three independent experiments (N2a cells at 662, 663 and 666 P). ** Data represent the mean ± SD of three microplates in one experiment (N2a cells at 810 P). *** Data represent the mean ± SD of one microplate in three independent experiments (N2a cells at 795, 797 and 798 P).